Quest Diagnostics Incorporated
Quest Diagnostics Incorporated (DGX) Stock Overview
Explore Quest Diagnostics Incorporated’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
20.2B
P/E Ratio
21.24
EPS (TTM)
$8.35
ROE
0.14%
DGX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Quest Diagnostics Incorporated (DGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 61.07, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $190.48.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.24 and a market capitalization of 20.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.